Seeking Alpha

Regeneron (REGN +1.8%) gains on positive comments out of BMO Capital this morning, saying that...

Regeneron (REGN +1.8%) gains on positive comments out of BMO Capital this morning, saying that Roche's (RHHBY.PK +2.5%) Lucentis market share is declining, and the number of patients switching to Eylea from other treatments is accelerating. The firm maintains an Outperform rating on the stock.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector